GenMark Diagnostics: 2Q Earnings Snapshot
Posted Aug 4, 2020 07:50:15 PM.
Last Updated Aug 4, 2020 07:54:12 PM.
This article is more than 5 years old.
CARLSBAD, Calif. (AP) _ GenMark Diagnostics Inc. (GNMK) on Tuesday reported a loss of $4.7 million in its second quarter.
The Carlsbad, California-based company said it had a loss of 7 cents per share.
The results topped Wall Street expectations. The average estimate of three analysts surveyed by Zacks Investment Research was for a loss of 10 cents per share.
The molecular diagnostics company posted revenue of $40.1 million in the period.
GenMark Diagnostics expects full-year revenue in the range of $155 million to $165 million.
GenMark Diagnostics shares have nearly quadrupled since the beginning of the year. In the final minutes of trading on Tuesday, shares hit $19.10, more than tripling in the last 12 months.
_____
This story was generated by Automated Insights (http://automatedinsights.com/ap) using data from Zacks Investment Research. Access a Zacks stock report on GNMK at https://www.zacks.com/ap/GNMK
The Associated Press
